Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (7891)	10/25/2001 6:22:49 PM
From: Cal Gary	Respond to of 14101

Was BRA, LOR and QLT. Now it HML's turn. HML just released 3Q. Very telling, check it out. Looks like their timeline pushed further into the future. HML shareholders only have HC approval end of year to look forward to now. Without FDA or EU MCA, I doubt HC will approve. Their operating burn rate is about $3mm per month and they also have capital spending. On a positive, they have about $95mm cash or 24-26 months of cash. Short term not so rosy. Midterm need for money. Longer term should be great. Deja Vu HML's path looking more and more like the one DMX has trod. E=MC2 Similar to BRA, with new HML info, in a way it bumps DMX relative timeliness forward against this bio peer. If only DMX got the same following, trade press coverage, and IR exposure, I'd bet a lot of HML money will find its way to DMX tomorrow. Sigh! Pennsaid Works, and Works NICE. If only the